Full Text View
Tabular View
No Study Results Posted
Related Studies
Detrol (Tolterodine) Post Surgery for Benign Prostatic Hyperplasia
This study is currently recruiting participants.
Study NCT00605319   Information provided by Weill Medical College of Cornell University
First Received: January 18, 2008   Last Updated: September 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bladder Outlet Obstruction
Additional conditions recognized in this trial
Prostatic Hyperplasia
Urinary Bladder Neck Obstruction
More general conditions related to this trial
Genital Diseases, Male
Prostatic Diseases
Urethral Diseases
Urethral Obstruction
Urinary Bladder Diseases
Urologic Diseases
Interventions listed in this trial
Detrol LA (Tolterodine)
Placebo
Additional drug interventions recognized in this trial
Tolterodine
More general drug interventions related to this trial
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Weill Medical College of Cornell University
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services